SLC5A2 and liver dysplastic nodule: During the period from 2016 to 2021, the results of both biclustering analyses and SNAs indicated that plant extract-based drugs and sodium-glucose cotransporter-2 (SGLT2) inhibitors have emerged as promising directions for the drug-based treatment of DN.